Starting this month, the Hydrocephalus Clinical Research Network (HCRN) will begin enrolling patients in a new study!
The study, A Randomized Controlled Trial of Anterior Versus Posterior Entry Site for Cerebrospinal Fluid Shunt Insertion, is a four year randomized clinical trial. The study will look at shunt entry points in both the anterior (front/top) and posterior (back) areas of the brain. The goal is to determine if either entry point decreases the need for repeated brain surgeries due to device failure. Dr. William Whitehead of Texas Children’s Hospital and Baylor College of Medicine, a principal investigator for the HCRN, developed and will oversee the trial which will accrue patients at all nine HCRN-participating pediatric hospitals.
Visit our new section – Patient Studies – for information about this and other hydrocephalus clinical trials being conducted around the world!